학술논문
Mavorixafor for Patients with Chronic Neutropenic Disorders: Results from a Phase 1b, Open-Label, Multicenter Study
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:1408-1410
Subject
Language
ISSN
0006-4971